1. Home
  2. GRDN vs SDGR Comparison

GRDN vs SDGR Comparison

Compare GRDN & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$30.06

Market Cap

1.7B

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$18.06

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
SDGR
Founded
2004
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
GRDN
SDGR
Price
$30.06
$18.06
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$32.00
$26.57
AVG Volume (30 Days)
310.2K
776.3K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$1,389,638,000.00
$256,951,000.00
Revenue This Year
$19.50
$23.69
Revenue Next Year
$0.48
$20.46
P/E Ratio
$110.34
N/A
Revenue Growth
18.68
32.90
52 Week Low
$17.78
$15.99
52 Week High
$37.43
$28.47

Technical Indicators

Market Signals
Indicator
GRDN
SDGR
Relative Strength Index (RSI) 56.51 50.16
Support Level $28.34 $17.53
Resistance Level $31.46 $18.28
Average True Range (ATR) 1.04 0.66
MACD 0.07 0.20
Stochastic Oscillator 55.02 66.25

Price Performance

Historical Comparison
GRDN
SDGR

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: